Minimize Uncertainty – Make Informed Decisions – Succeed

Lucid Diligence Brief - Tech

Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration

January 31, 2026market access,clinical development,obesity,GLP-1,biopharma,licensing,Lucid Diligence Brief,payer access,metabolic disease,manufacturing,AI in drug discoveryChina strategy

Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration…

by Timos Papagatsias

Public_Health

Public Health Video Recap—January 30, 2026

January 30, 2026Barnacle-derived CP43K/TFF3,Bifidobacteria probiotics,breast cancer,Inflammatory bowel disease (IBD),Asthma,Allergies,BioPharma and Tech News,Heart attack,Colorectal Cancer,ctDNA,Public Health News,Chronic inflammation,IgE,4-OH-PLA,Epoxy-oxylipins,sEH inhibitors,GSK2256294Canakinumab,Ilaris

This biweekly Public Health video recap summarizes the latest developments…

by LucidQuest

Public_Health

Public Health Today—30 January, 2026

January 30, 20264-hydroxyphenyl lactate,alcohol,climate change,IL-1β,Alzheimer's Disease,circadian rhythm,BioPharma and Tech News,BPA,Colorectal Cancer,TRPV1,menopause,Public Health News,malaria,Epstein Barr virus,Oats,LDL cholesterol,University of BonnNaegleria fowleri,bifidobacteria

This week’s public health update covers key developments across infectious…

by LucidQuest

Vaccines

Vaccines Today—January 30, 2026

January 30, 2026gsk,cancer vaccines,BioPharma and Tech News,melanoma vaccine,RSV Vaccine,HIV vaccine,Vaccine news,Ebola vaccine,universal COVID vaccine,therapeutic DNA vaccineImmuno Cure,SK biosciences

This week's Vaccines update in the summarizes the latest advancements including…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from CTFH

January 30, 2026clinical trials,drug development,Regulatory,immunology,IBD,biopharma,licensing,Lucid Diligence Brief,payer access,diligencemicroRNA

Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from…

by Timos Papagatsias

Respiratory

Respiratory Today—January 30, 2026

January 30, 2026gsk,Asthma,BioPharma and Tech News,Dupilumab,NICE,Idiopathic Pulmonary Fibrosis,pulmonary arterial hypertension,Respiratory News,chronic obstructive pulmonary diseaseTrelegy Ellipta,nalbuphine ER

This is the weekly update in respiratory therapy, summarizing the latest…

by LucidQuest

Rare Disease news

Rare Disease Video Recap—January 29, 2026

January 29, 2026Opna Bio,Zavabresib,Duchenne Muscular Dystrophy,AQNEURSA,BioPharma and Tech News,Immune-complex membranoproliferative glomerulonephritis,Netherton syndrome,Atossa Therapeutics,myelofibrosis,Tanabe Pharma,Cushing’s disease,Recordati Rare Diseases,Rare Disease News,IntraBio,Isturisa,Quoin Pharmaceuticals,Mirum Pharmaceuticals,Erythropoietic protoporphyria,Bluejay Therapeutics,X-linked hypophosphatemia,Niemann–Pick disease type C,(Z)-Endoxifen,C3 glomerulopathySobi,Aspaveli

This biweekly Rare Disease Video Recap highlights significant regulatory…

by LucidQuest

Cardiovascular

Cardiovascular Video Recap—January 29, 2026

January 29, 2026Rybelsus,Testosterone,semaglutide,Estradiol,bayer,BioPharma and Tech News,Cardiovascular Disease,Atrial fibrillation,stroke,menopause,Repatha,Vanderbilt University Medical Center,Evolocumab,Cardiovascular News,AbbottPerimenopause,Asundexian

This biweekly Cardiovascular Video Recap reviews regulatory actions, late-stage…

by LucidQuest

Cardiovascular

Cardiovascular Today—January 29, 2026

January 29, 2026BioPharma and Tech News,HEART FAILUREAtrial fibrillation,Medtronic,Cardiovascular News,Abbott,Structural heart disease,mitral regurgitation,pulsed field ablation,transcatheter valve replacement,PCSK9 inhibitors

This is a weekly update in cardiovascular medicine, covering regulatory…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—January 29, 2026

January 29, 2026gene editing,Duchenne Muscular Dystrophy,Sickle Cell Disease,BioPharma and Tech News,CAR T Therapy,Glioblastoma,Cell and Gene Therapy News,CAR-NK therapy,cell therapy manufacturingFDA Breakthrough Therapy Designation,Sarepta Therapeutics

This week’s Cell and Gene Therapy update highlights significant advancements,…

by LucidQuest

Rare Disease news

Rare Diseases Today—January 29, 2026

January 29, 2026BioPharma and Tech News,Hunter SyndromeNetherton syndrome,Orphan Drug Designation,myelofibrosis,Rare Disease News,Mirum Pharmaceuticals,Niemann-Pick Type C disease,Rare pediatric disease designation,AQNEURSA,Curant Rare

This week's rare disease updates focus on significant regulatory approvals,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Seamless Therapeutics and Lilly enter gene-writing pact in hearing loss

January 29, 2026clinical trials,AAV,gene therapy,Regulatory,gene editing,biopharma,Lucid Diligence Brief,payer access,diligence,hearing lossinvestors

Lucid Diligence Brief: Seamless Therapeutics and Lilly enter gene-writing pact…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.